Trial
NCT00230607
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Fabry Disease
Intervention
agalsidase beta
Why stopped
Per FDA decision, the 2003 Post Marketing commitment has been fulfilled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-10